- Sponsors’ roles in supporting sites in order to increase trial efficiency and decrease overall timelines
- Where can clinical trial sponsors better support patients with rare diseases both during trials and in the long term?
- Lessons learned from Moderna’s experience of site and patient engagement during clinical trials